TY - JOUR
T1 - Titin copy number variations associated with dominant inherited phenotypes
AU - Perrin, Aurélien
AU - Métay, Corinne
AU - Savarese, Marco
AU - Ben Yaou, Rabah
AU - Demidov, German
AU - Nelson, Isabelle
AU - Solé, Guilhem
AU - Péréon, Yann
AU - Bertini, Enrico Silvio
AU - Fattori, Fabiana
AU - D'amico, Adele
AU - Ricci, Federica
AU - Ginsberg, Mira
AU - Seferian, Andreea
AU - Boespflug-Tanguy, Odile
AU - Servais, Laurent
AU - Chapon, Françoise
AU - Lagrange, Emmeline
AU - Gaudon, Karen
AU - Bloch, Adrien
AU - Ghanem, Robin
AU - Guyant-Maréchal, Lucie
AU - Johari, Mridul
AU - Van Goethem, Charles
AU - Fardeau, Michel
AU - Morales, Raul Juntas
AU - Genetti, Casie A.
AU - Marttila, Minttu
AU - Koenig, Michel
AU - Beggs, Alan
AU - Udd, Bjarne
AU - Bonne, Gisèle
AU - Cossée, Mireille
N1 - Funding Information:
This work was funded by AFM 21381 and 24259 grants (the French Muscular Dystrophy Association (AFM-Téléthon)); the Délégation à la Recherche Clinique et à l’Innovation du Groupement de Coopération Sanitaire de la Mission d’Enseignement, de Recherche, de Référence et d’Innovation (DRCI-GCS-MERRI) de Montpellier-Nîmes and the Solve-RD Project have received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no 779257. Analysis of family H was supported by Muscular Dystrophy Association (USA) grant MDA602235, Boston Children’s Hospital IDDRC Molecular Genetics Core Facility funded by P50HD105351 from the National Institutes of Health of USA, the Boston Children’s Hospital CRDC Initiative and by a sponsored research agreement with GeneDx. Some coauthors are members of the ERN NMD Network (AD'A, FF, OB-T, MS, RBY, IN, GS, YP, ESB, AS, MJ, BU, GB).
Publisher Copyright:
© 2023 Author(s) (or their employer(s)).
PY - 2023/11/7
Y1 - 2023/11/7
N2 - Background: Titinopathies are caused by mutations in the titin gene (TTN). Titin is the largest known human protein; its gene has the longest coding phase with 364 exons. Titinopathies are very complex neuromuscular pathologies due to the variable age of onset of symptoms, the great diversity of pathological and muscular impairment patterns (cardiac, skeletal muscle or mixed) and both autosomal dominant and recessive modes of transmission. Until now, only few CNVs in TTN have been reported without clear genotype-phenotype associations. Methods: Our study includes eight families with dominant titinopathies. We performed next-generation sequencing or comparative genomic hybridisation array analyses and found CNVs in the TTN gene. We characterised these CNVs by RNA sequencing (RNAseq) analyses in six patients' muscles and performed genotype-phenotype inheritance association study by combining the clinical and biological data of these eight families. Results: Seven deletion-type CNVs in the TTN gene were identified among these families. Genotype and RNAseq results showed that five deletions do not alter the reading frame and one is out-of-reading frame. The main phenotype identified was distal myopathy associated with contractures. The analysis of morphological, clinical and genetic data and imaging let us draw new genotype-phenotype associations of titinopathies. Conclusion: Identifying TTN CNVs will further increase diagnostic sensitivity in these complex neuromuscular pathologies. Our cohort of patients enabled us to identify new deletion-type CNVs in the TTN gene, with unexpected autosomal dominant transmission. This is valuable in establishing new genotype-phenotype associations of titinopathies, mainly distal myopathy in most of the patients.
AB - Background: Titinopathies are caused by mutations in the titin gene (TTN). Titin is the largest known human protein; its gene has the longest coding phase with 364 exons. Titinopathies are very complex neuromuscular pathologies due to the variable age of onset of symptoms, the great diversity of pathological and muscular impairment patterns (cardiac, skeletal muscle or mixed) and both autosomal dominant and recessive modes of transmission. Until now, only few CNVs in TTN have been reported without clear genotype-phenotype associations. Methods: Our study includes eight families with dominant titinopathies. We performed next-generation sequencing or comparative genomic hybridisation array analyses and found CNVs in the TTN gene. We characterised these CNVs by RNA sequencing (RNAseq) analyses in six patients' muscles and performed genotype-phenotype inheritance association study by combining the clinical and biological data of these eight families. Results: Seven deletion-type CNVs in the TTN gene were identified among these families. Genotype and RNAseq results showed that five deletions do not alter the reading frame and one is out-of-reading frame. The main phenotype identified was distal myopathy associated with contractures. The analysis of morphological, clinical and genetic data and imaging let us draw new genotype-phenotype associations of titinopathies. Conclusion: Identifying TTN CNVs will further increase diagnostic sensitivity in these complex neuromuscular pathologies. Our cohort of patients enabled us to identify new deletion-type CNVs in the TTN gene, with unexpected autosomal dominant transmission. This is valuable in establishing new genotype-phenotype associations of titinopathies, mainly distal myopathy in most of the patients.
KW - genetics
KW - genomics
KW - human genetics
KW - neuromuscular diseases
UR - http://www.scopus.com/inward/record.url?scp=85176928779&partnerID=8YFLogxK
U2 - 10.1136/jmg-2023-109473
DO - 10.1136/jmg-2023-109473
M3 - Article
C2 - 37935568
AN - SCOPUS:85176928779
SN - 0022-2593
JO - Journal of Medical Genetics
JF - Journal of Medical Genetics
ER -